Laurie B. Joseph, Ph.D.

Investigator
Associate Research Professor, Pharmacology & Toxicology, Ernest Mario School of Pharmacy, Rutgers University

[Link to Bio] [Back to Members Page]

Recent Publications

Lackey, AI, Chen, T, Zhou, YX, Bottasso Arias, NM, Doran, JM, Zacharisen, SM, Gajda, AM, Córsico, B, Joseph, LB, Storch, J. Mechanisms underlying reduced weight gain in Intestinal Fatty Acid-Binding Protein (IFABP) null mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2020; :. PubMed PMID:31905021 .

Szilagyi, JT, Composto-Wahler, GM, Joseph, LB, Wang, B, Rosen, T, Laskin, JD, Aleksunes, LM. Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis. Pharmacol. Res. 2019;141 :331-342. PubMed PMID:30610963 PubMed Central PMC6391190.

Moretti, A, Li, Q, Chmielowski, R, Joseph, LB, Moghe, PV, Uhrich, KE. Nanotherapeutics Containing Lithocholic Acid-Based Amphiphilic Scorpion-Like Macromolecules Reduce In Vitro Inflammation in Macrophages: Implications for Atherosclerosis. Nanomaterials (Basel). 2018;8 (2):. PubMed PMID:29393918 PubMed Central PMC5853716.

Joseph, LB, Composto, GM, Perez, RM, Kim, HD, Casillas, RP, Heindel, ND, Young, SC, Lacey, CJ, Saxena, J, Guillon, CD, Croutch, CR, Laskin, JD, Heck, DE. Sulfur mustard induced mast cell degranulation in mouse skin is inhibited by a novel anti-inflammatory and anticholinergic bifunctional prodrug. Toxicol. Lett. 2018;293 :77-81. PubMed PMID:29127031 PubMed Central PMC5938161.

Chmielowski, RA, Abdelhamid, DS, Faig, JJ, Petersen, LK, Gardner, CR, Uhrich, KE, Joseph, LB, Moghe, PV. Athero-inflammatory nanotherapeutics: Ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation. Acta Biomater. 2017;57 :85-94. PubMed PMID:28522412 PubMed Central PMC5546209.

Faig, JJ, Moretti, A, Joseph, LB, Zhang, Y, Nova, MJ, Smith, K, Uhrich, KE. Biodegradable Kojic Acid-Based Polymers: Controlled Delivery of Bioactives for Melanogenesis Inhibition. Biomacromolecules. 2017;18 (2):363-373. PubMed PMID:28026947 PubMed Central PMC5810376.

Lacey, CJ, Wohlman, I, Guillon, C, Saxena, J, Fianu-Velgus, C, Aponte, E, Young, SC, Heck, DE, Joseph, LB, Laskin, JD, Heindel, ND. Multi-inhibitor prodrug constructs for simultaneous delivery of anti-inflammatory agents to mustard-induced skin injury. Ann. N. Y. Acad. Sci. 2016;1378 (1):174-179. PubMed PMID:27505078 PubMed Central PMC5063683.

Joseph, LB, Composto, GM, Heck, DE. Tissue injury and repair following cutaneous exposure of mice to sulfur mustard. Ann. N. Y. Acad. Sci. 2016;1378 (1):118-123. PubMed PMID:27371823 PubMed Central PMC5063676.

Composto, GM, Laskin, JD, Laskin, DL, Gerecke, DR, Casillas, RP, Heindel, ND, Joseph, LB, Heck, DE. Mitigation of nitrogen mustard mediated skin injury by a novel indomethacin bifunctional prodrug. Exp. Mol. Pathol. 2016;100 (3):522-31. PubMed PMID:27189522 PubMed Central PMC4947376.

Wohlman, IM, Composto, GM, Heck, DE, Heindel, ND, Lacey, CJ, Guillon, CD, Casillas, RP, Croutch, CR, Gerecke, DR, Laskin, DL, Joseph, LB, Laskin, JD. Mustard vesicants alter expression of the endocannabinoid system in mouse skin. Toxicol. Appl. Pharmacol. 2016;303 :30-44. PubMed PMID:27125198 PubMed Central PMC4947375.

More Publications